课题基金 / 基金详情

Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice

Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
药物与非药物选择决策决定因素的多模态临床前成像研究
批准号:
10928580
负责人:
Charles Bradberry
金额:
$319.75万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Charles Bradberry的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the most effective addiction treatments is contingency management, in which alternate rewards are offered in exchange for abstention. We model this approach by establishing economic choice in lab animals using touch screens that display quantity signifying stimuli and detect choice responses. The economic nature of the choices animals make was verified by devaluation of milk reward through satiation, or drug (remifentanil) reward through saline substitution. To manipulate specific circuits, we are collaborating with other labs to develop focused ultrasound stimulation approaches, as well as a chemogenetic toolbox for primates that could establish their potential application in the clinic. Progress in the past year includes establishing high resolution awake nonhuman primate PET imaging, and initiation of investigation of newly emerging focused ultrasound manipulations of neural tissue. As we refine this approach, the awake PET studies will be used to help characterize effects on defined neural systems using 18F-fluorodeoxyglucose to measure localized relative cerebral metabolic rate. Complimentary studies will build upon a recently accepted paper in which we model contingency management approaches with an imposed "deliberative" mode of processing, which we contrast with an "immediate impulsive" mode of processing. These two modes will be contrasted during awake PET studies in a block contrast design.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Effects of buprenorphine, methadone, and cariprazine on economic choice between remifentanil and food in squirrel monkeys.
丁丙诺啡、美沙酮和卡利拉嗪对松鼠猴瑞芬太尼和食物经济选择的影响。
DOI: 10.1016/j.addicn.2023.100065
发表时间: 2023
期刊: Addiction neuroscience
影响因子: --
作者: [Amirali,AlishanS, Hecker,JacquelinC, Figueroa,HectorM, Effinger,DevinP, Montoro,RodrigoA, Jedema,HankP, Vogt,CalebD, Newman,AmyHauck, Schindler,CharlesW, Bradberry,CharlesW]
通讯作者: Bradberry,CharlesW
DOI: 10.1007/s00213-017-4726-2
发表时间: 2017-11
期刊: Psychopharmacology
影响因子: 3.4
作者: [Panlilio LV, Secci ME, Schindler CW, Bradberry CW]
通讯作者: Bradberry CW
DOI: 10.1038/s41386-021-00996-6
发表时间: 2022-06
期刊: NEUROPSYCHOPHARMACOLOGY
影响因子: 7.6
作者: [Brown, Samantha O., Effinger, Devin P., Montoro, Rodrigo A., Daddaoua, Nabil, Justinova, Zuzana, Moerke, Megan J., Schindler, Charles W., Jedema, Hank P., Bradberry, Charles W.]
通讯作者: Bradberry, Charles W.
DOI: 10.1016/j.pbb.2021.173147
发表时间: 2021-05
期刊: Pharmacology, biochemistry, and behavior
影响因子: --
作者: [Boehm MA, Bonaventura J, Gomez JL, Solís O, Stein EA, Bradberry CW, Michaelides M]
通讯作者: Michaelides M
6
    Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
    • 批准号:
      10699663
    • 项目类别:
    • 资助金额:
      $290.16万
    • 财政年份:
      --
    • 负责人:
      Charles Bradberry
    • 依托单位:
    Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
    • 批准号:
      10268819
    • 项目类别:
    • 资助金额:
      $214.44万
    • 财政年份:
      --
    • 负责人:
      Charles Bradberry
    • 依托单位:
    海外基金